MAPT and Alzheimer disease: Astrocyte reactivity, involving transcriptional, morphological, and functional changes in astrocytes in response to Aβ and tau, is also a key feature of AD (Escartin et al., 2021; Perez‐Nievas & Serrano‐Pozo, 2018).